In vivo quantitative imaging of dopamine receptors in human brain using positron emission tomography and [76Br]bromospiperone
- 1 August 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 114 (3), 267-272
- https://doi.org/10.1016/0014-2999(85)90369-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 76Br-bromospiroperidol: A new tool for quantitative in-vivo imaging of neuroleptic receptorsLife Sciences, 1984
- Carrier-added and no-carrier-added syntheses of [18F]spiroperidol and [18F]haloperidolThe International Journal of Applied Radiation and Isotopes, 1984
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984
- Preparation and purification of 77Br‐labelled p‐bromospiroperidol suitable for in vivo dopamine receptor studiesJournal of Labelled Compounds and Radiopharmaceuticals, 1983
- Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical EffectsJournal of Computer Assisted Tomography, 1981
- Synthesis and biological evaluation of p-bromospiperone as potential neuroleptic drugJournal of Pharmaceutical Sciences, 1980
- INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIAThe Lancet, 1978
- Receptor basis for dopaminergic supersensitivity in Parkinson's diseaseNature, 1978
- Alterations in dopaminergic receptors in Huntington's diseaseLife Sciences, 1977
- Neurotransmitter receptor alterations in Parkinson's diseaseLife Sciences, 1977